Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study

De Luca, A Baldini, F Cingolani, A Di Giambenedetto, S Zaccarelli, M Tozzi, V Ammassari, A Murri, R Antinori, A

A. De Luca et al., Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study, AIDS, 14(11), 2000, pp. 1655-1656

10

Immunology

AIDS

02699370 → ACNP

14

11

2000

1655 - 1656

ISI

0269-9370(20000728)14:11<1655:BAROSF>2.0.ZU;2-4